Difference between revisions of "Part:BBa K3346004:Design"
(One intermediate revision by the same user not shown) | |||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | Restriction enzyme sites were removed and sequence was optimized for use in E. coli. | + | Restriction enzyme sites were removed and sequence was optimized for use in E. coli using Reverse Translate Software available on The Sequence Manipulation Suite. |
Latest revision as of 21:24, 23 October 2020
Anti-Estradiol Fab Fragment
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Restriction enzyme sites were removed and sequence was optimized for use in E. coli using Reverse Translate Software available on The Sequence Manipulation Suite.
Source
This sequence comes from (mouse) monoclonal antibody 57-2 anti-17beta-estradiol.